control trial adjuv immunotherapi murin monoclon antibodi resect pancreat cancer prospect multicentr trial patient hospit resect pancreat cancer patient whippl resect week surgeri patient intraven IV treatment mg mg dose mg day monoclon antibodi moab behringwerk AG marsburg germani addit anti-canc treatment murin immunoglobulin Ig antibodi human pancreat cancer cell antibody-depend cellular cytotox adcc studi group respect age sex tumor stage patient minor toxic abdomin pain immunotherapi month end recruit period patient treatment control group live patient aliv recurr progress cancer diseas median surviv time day rang day day rang day treatment control group author IV treatment antibodi help resect pancreat cancer studi first data passiv immunotherapi solid cancer 